Clinical trials
Phase 2 Carcinoma, Lobular trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2005 | 2 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 3 |
| 2014 | 1 |
| 2016 | 1 |
| 2020 | 1 |
| 2024 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 4 |
| Completed | 4 |
| Recruiting | 3 |
| Terminated | 3 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| City of Hope Medical Center | 2 |
| Dana-Farber Cancer Institute | 2 |
| Rutgers, The State University of New Jersey | 2 |
| Case Comprehensive Cancer Center | 1 |
| M.D. Anderson Cancer Center | 1 |
| Memorial Sloan Kettering Cancer Center | 1 |
| Radiation Therapy Oncology Group | 1 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 1 |
| University of Alabama at Birmingham | 1 |
| University of Utah | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Lobular | 15 |
| Breast Neoplasms | 11 |
| Carcinoma, Ductal, Breast | 8 |
| Carcinoma, Intraductal, Noninfiltrating | 4 |
| Inflammatory Breast Neoplasms | 4 |
| Breast Neoplasms, Male | 3 |
| Breast Carcinoma In Situ | 2 |
| Neoplasm Metastasis | 1 |
| Neoplastic Cells, Circulating | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.